Association of diabetes mellitus with hepatitis B and hepatitis C virus infection: evidence from an epidemiological study

References

• Cho N, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281. doi:10.1016/j.diabres.2018.02.02329496507
   PubMed Web of Science ®Google Scholar
• Koye DN, Magliano DJ, Nelson RG, Pavkov ME. The global epidemiology of diabetes and kidney disease. Adv Chronic Kidney Dis. 2018;25(2):121–132. doi:10.1053/j.ackd.2017.10.01129580576
   PubMed Web of Science ®Google Scholar
• Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414(6865):799. doi:10.1038/414799a11742412
   PubMed Web of Science ®Google Scholar
• Parhofer KG. Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia. Diabetes Metab J. 2015;39(5):353–362. doi:10.4093/dmj.2015.39.5.35326566492
   PubMed Web of Science ®Google Scholar
• Adiels M, Olofsson SO, Taskinen MR, Borén J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28(7):1225–1236. doi:10.1161/ATVBAHA.107.16019218565848
   PubMed Web of Science ®Google Scholar
• Ozder A. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study. Lipids Health Dis. 2014;13(1):183. doi:10.1186/1476-511X-13-18325481115
   PubMed Web of Science ®Google Scholar
• Yonghao G, Jin X, Jun L, et al. An epidemiological serosurvey of hepatitis B virus shows evidence of declining prevalence due to hepatitis B vaccination in central China. Int J Infect Dis. 2015;1(40):75–80. doi:10.1016/j.ijid.2015.10.002
   Web of Science ®Google Scholar
• Bose SK, Ray R. Hepatitis C virus infection and insulin resistance. World J Diabetes. 2014;5(1):52. doi:10.4239/wjd.v5.i1.5224567801
   PubMedGoogle Scholar
• El-Zayadi AR, Anis M. Hepatitis C virus induced insulin resistance impairs response to anti-viral therapy. World J Gastroenterol. 2012;18(3):212. doi:10.3748/wjg.v18.i3.21222294824
   PubMed Web of Science ®Google Scholar
• Lok AS, McMahon BJ, Brown RS, et al. Antiviral therapy for chronic hepatitis B viral infection in adults: a systematic review and meta-analysis. Hepatology. 2016;63(1):284–306. doi:10.1002/hep.2828026566246
   PubMed Web of Science ®Google Scholar
• Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010;14(1):1–21. doi:10.1016/j.cld.2009.11.00920123436
   PubMedGoogle Scholar
• Zhang Y, Chen LM, He M. Hepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution. Virol J. 2017;14(1):41. doi:10.1186/s12985-017-0710-z28231805
   PubMed Web of Science ®Google Scholar
• Desbois AC, Cacoub P. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review. World J Gastroenterol. 2017;23(9):1697. doi:10.3748/wjg.v23.i9.169728321170
   PubMed Web of Science ®Google Scholar
• El–Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006;4(3):369–380. doi:10.1016/j.cgh.2005.12.00716527702
   PubMed Web of Science ®Google Scholar
• Huang JF, Dai CY, Hwang SJ, et al. Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication. Am J Gastroenterol. 2007;102(6):1237. doi:10.1111/j.1572-0241.2007.01181.x17531012
   PubMed Web of Science ®Google Scholar
• Sangiorgio L, Attardo T, Gangemi R, Rubino C, Barone M, Lunetta M. Increased frequency of HCV and HBV infection in type 2 diabetic patients. Diabetes Res Clin Pract. 2000;48(2):147–151.10802152
   PubMed Web of Science ®Google Scholar
• Balogun WO, Adeleye JO, Akinlade KS, Kuti M, Otegbayo JA. Low prevalence of hepatitis-C viral seropositivity among patients with type-2 diabetes mellitus in a tertiary hospital. J Natl Med Assoc. 2006;98(11):1805.17128691
   PubMed Web of Science ®Google Scholar
• Costa LM, Mussi AD, Brianeze MR, Souto FJ. Hepatitis C as a risk factor for diabetes type 2: lack of evidence in a hospital in central-west Brazil. Braz J Infect Dis. 2008;12(1):24–26.18553010
   PubMed Web of Science ®Google Scholar
• Zhang J, Shen Y, Cai H, Liu YM, Qin G. Hepatitis B virus infection status and risk of type 2 diabetes mellitus: a meta-analysis. Hepatol Res. 2015;45(11):1100–1109. doi:10.1111/hepr.1248125601609
   PubMed Web of Science ®Google Scholar
• Bi Y, Lu J, Wang W, et al. Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study. J Diabetes. 2014;6(2):147–157. doi:10.1111/1753-0407.1210824237858
   PubMed Web of Science ®Google Scholar
• Montenegro L, De Michina A, Misciagna G, Guerra V, Di Leo A. Virus C hepatitis and type 2 diabetes: a cohort study in southern Italy. Am J Gastroenterol. 2013;108(7):1108. doi:10.1038/ajg.2013.9023567360
   PubMed Web of Science ®Google Scholar
• Custro N, Carroccio A, Ganci A, et al. Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis. Diabetes Metab. 2001;27(4 Pt 1):476–481.11547221
   PubMed Web of Science ®Google Scholar
• Hammerstad SS, Grock SF, Lee HJ, Hasham A, Sundaram N, Tomer Y. Diabetes and hepatitis C: a two-way association. Front Endocrinol (Lausanne). 2015;14(6):134.
   Google Scholar
• White DL, Ratziu V, El-Serag HB. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol. 2008;49(5):831–844. doi:10.1016/j.jhep.2008.08.00618814931
   PubMed Web of Science ®Google Scholar
• Strassburg CP, Vogel A, Manns MP. Autoimmunity and hepatitis C. Autoimmun Rev. 2003;2(6):322–331.14550873
   PubMed Web of Science ®Google Scholar
• Cacoub P, Poynard T, Ghillani P, et al. Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum. 1999;42(10):2204–2212. doi:10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D10524695
   PubMed Web of Science ®Google Scholar
• Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999;29(2):328–333. doi:10.1002/hep.5102902359918906
   PubMed Web of Science ®Google Scholar
• Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006;28(1):112–125. doi:10.1093/epirev/mxj00916754644
   PubMed Web of Science ®Google Scholar
• Williams I. Epidemiology of hepatitis C in the United States. Am J Med. 1999;107(6):2–9. doi:10.1016/S0002-9343(99)00373-3
   Google Scholar
• Wu L, Parhofer KG. Diabetic dyslipidemia. Metabolism. 2014;63(12):1469–1479. doi:10.1016/j.metabol.2014.08.01025242435
   PubMed Web of Science ®Google Scholar